Comcast (CMCSA, $42.59) to release an in-home health device later this year
Presently, the health innovation segment at Comcast is working on an in-home device to monitor people’s health, especially at-risk people like seniors and the ones with disabilities, and plans to start pilot-testing later this year. The pricing and roll-out time is yet to be finalized.
The company has been working on the device for more than a year now and under the guidance of the new senior vice president and health manager, it is building a strategy and a team to bring the new health hardware to market.
The said device will be able to monitor people’s basic health metrics using ambient sensors and will particularly focus on whether someone is frequenting the bathroom more often or spending more time in bed than normal. Comcast is also designing tools to detect falls which are common and sometimes fatal among elderly people.
What differentiates the device is that it won’t be positioned as communication or assistant tool and won’t follow search instructions on the web. But it will take after the personality of Alexa and will be able to make emergency calls during a health event.
Though Comcast already has devices pertaining to home security and automation, the said device would be the first of its kind in the health segment. The company has already partnered with several insurers like Independence Health Group to explore opportunities in the health sector a few years ago.
With this device, Comcast will join the cohort of technology companies like Google (GOOG, GOOGL), Amazon (AMZN), and Apple (AAPL) that are already looking at exploring opportunities in senior living facilities, fall detection, and heart health tracking.
Another differentiator for Comcast among the aging population will be its access to the home through its cable and broadband business which means technicians can make house calls for installations. The company aims to act as a measure so that aging patients do not end up in hospitals soon after their release.
CMCSA sees MACD Histogram crosses below signal line
CMCSA saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 15, 2024. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 50 instances where the indicator turned negative. In of the 50 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for CMCSA moved out of overbought territory on November 07, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on December 05, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on CMCSA as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CMCSA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CMCSA broke above its upper Bollinger Band on November 06, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 55 cases where CMCSA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CMCSA advanced for three days, in of 330 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 222 cases where CMCSA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.030) is normal, around the industry mean (4.726). P/E Ratio (11.391) is within average values for comparable stocks, (113.894). Projected Growth (PEG Ratio) (0.689) is also within normal values, averaging (8.093). Dividend Yield (0.027) settles around the average of (0.059) among similar stocks. P/S Ratio (1.442) is also within normal values, averaging (13.458).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CMCSA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CMCSA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
General Information
a provider of entertainment, information and communications products and services
Industry WirelessTelecommunications